Identification and Targeting of Regulators of SARS-CoV-2-Host Interactions in the Airway Epithelium.

Brooke Greer Dirvin,Heeju Noh,Lorenzo Tomassoni,Danting Cao,Yizhuo Zhou,Xiangyi Ke,Jun Qian,Michael Schotsaert,Adolfo Garcia-Sastre,Charles Karan,Andrea Califano,Wellington V. Cardoso

DOI: https://doi.org/10.1101/2024.10.11.617898

2024-10-14

Abstract:Although the impact of SARS-CoV-2 in the lung has been extensively studied, the molecular regulators and targets of the host-cell programs hijacked by the virus in distinct human airway epithelial cell populations remain poorly understood. This is in part ascribed to the use of non- primary cell systems, overreliance on single-cell gene expression profiling that not ultimately reflect protein activity and bias toward the downstream effects rather than their mechanistic determinants. Here we address these issues by network-based analysis of single cell transcriptomic profiles of pathophysiologically relevant human adult basal, ciliated and secretory cells to identify master regulator (MR) protein modules controlling their SARS-CoV-2-mediated reprogramming. This uncovered chromatin remodeling, endosomal sorting, ubiquitin pathway as well as proviral factors identified by CRISPR analyses as components of the host response collectively or selectively activated in these cells. Large-scale perturbation assays, using a clinically-relevant drug library, identified 11 drugs able to invert the entire MR signature activated by SARS-CoV-2 in these cell types. Leveraging MR analysis and perturbational profiles of human primary cells, represents a novel mechanism-based approach and resource that can be directly generalized to interrogate signatures of other airway conditions for drug prioritization.

Cell Biology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to understand the molecular regulators and targets of how SARS - CoV - 2 hijacks host cell programs in human airway epithelial cells. Specifically, the research aims to:

1. **Identify key regulatory proteins**: Through network analysis of single - cell transcriptome profiles, determine the major regulator (Master Regulator, MR) modules that control SARS - CoV - 2 - mediated reprogramming. These modules are activated or selectively activated in different airway epithelial cell types (such as basal cells, ciliated cells, and secretory cells).

2. **Reveal virus - host interaction mechanisms**: The research not only focuses on the overall effect but also pays special attention to specific responses in different cell subpopulations to reveal the specific mechanisms of how SARS - CoV - 2 hijacks host functions in these cells.

3. **Screen for potential drugs**: Through large - scale perturbation experiments, using a clinically relevant drug library, screen for drugs that can reverse the MR signature activated by SARS - CoV - 2. The research finally identified 11 drugs that can target the SARS - CoV - 2 - mediated MR signature in three airway subpopulation cells.

4. **Provide method and resource with mechanistic basis**: Proposed a network - based method (ViroTreat), which can be used to study airway conditions caused by other pathogens and provide resources for drug prioritization.

Through these studies, the paper aims to fill the gaps in existing research, especially those relying on non - physiological cell lines or cancer cell lines, which have limitations in revealing tissue - or cell - type - specific disease mechanisms. The paper uses a human primary cell culture system closer to physiological conditions, thereby providing a more accurate and detailed virus - host interaction mechanism.